Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 359748, 10 pages
http://dx.doi.org/10.1155/2014/359748
Review Article

The Dual Role of HLA-G in Cancer

1CEA, Institut des Maladies Emergentes et des Therapies Innovantes (IMETI), Service de Recherche en Hemato-Immunologie (SRHI), Hopital Saint-Louis, 75010 Paris, France
2Université Paris Diderot, Sorbonne Paris Cité, IUH, Hopital Saint-Louis, UMR_E5, 75010 Paris, France

Received 7 January 2014; Accepted 25 February 2014; Published 31 March 2014

Academic Editor: Fabio Morandi

Copyright © 2014 Nathalie Rouas-Freiss et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [51 citations]

The following is the list of published articles that have cited the current article.

  • Takele Teklemariam, Longmei Zhao, and Basil M Hantash, “ Heterologous expression of mutated HLA-G1 reduces alloreactivity of human dermal fibroblasts ,” Regenerative Medicine, vol. 9, no. 6, pp. 775–784, 2014. View at Publisher · View at Google Scholar
  • Marwoto, Afiono Agung Prasetyo, Ratna Sariyatun, Suradi, Reviono, and Harsinia, “Human Leukocyte Antigen-G (HLA-G) 14-bp deletion polymorphism is associated with decreased risk of pulmonary fibrosis in Indonesian Javanese patients ,” Asian Biomedicine, vol. 9, no. 4, pp. 473–479, 2015. View at Publisher · View at Google Scholar
  • Edgardo D. Carosella, Guillaume Ploussard, Joel LeMaoult, and Francois Desgrandchamps, “A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G,” European Urology, vol. 68, no. 2, pp. 267–279, 2015. View at Publisher · View at Google Scholar
  • Emilia Andersson, Isabel Poschke, Lisa Villabona, Joseph W. Carlson, Andreas Lundqvist, Rolf Kiessling, Barbara Seliger, and Giuseppe V. Masucci, “Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumour infiltrating immune cells and prognosis,” OncoImmunology, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • A. Wisniewski, A. Kowal, E. Wyrodek, I. Nowak, E. Majorczyk, M. Wagner, E. Pawlak-Adamska, R. Jankowska, B. Slesak, I. Frydecka, and P. Kusnierczyk, “Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer,” Tissue Antigens, vol. 85, no. 6, pp. 466–475, 2015. View at Publisher · View at Google Scholar
  • Simon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, Chiara Massa, Juliane Braun, Stefan Hüttelmaier, Verena Spath, Roland Wartenberg, Wolfgang Legal, Helge Taubert, Sven Wach, Bernd Wullich, Arndt Hartmann, and Barbara Seliger, “Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma,” OncoImmunology, vol. 4, no. 6, pp. e1008805, 2015. View at Publisher · View at Google Scholar
  • Joel LeMaoult, Julien Caumartin, Marina Daouya, Magdalena Switala, Vera Rebmann, Bertrand Arnulf, and Edgardo D Carosella, “Trogocytic intercellular membrane exchanges among hematological tumors,” Journal of Hematology & Oncology, vol. 8, no. 1, 2015. View at Publisher · View at Google Scholar
  • Katharina Geissler, Paolo Fornara, Christine Lautenschläger, Hans-Jürgen Holzhausen, Barbara Seliger, and Dagmar Riemann, “Immune signature of tumor infiltrating immune cells in renal cancer,” OncoImmunology, vol. 4, no. 1, pp. e985082, 2015. View at Publisher · View at Google Scholar
  • Iris N. Pardieck, Priscilla A. Jawahier, Marloes Swets, Cornelis J.H. van de Velde, and Peter J.K. Kuppen, “Novel avenues in immunotherapies for colorectal cancer,” Expert Review of Gastroenterology & Hepatology, pp. 1–16, 2015. View at Publisher · View at Google Scholar
  • Marica Garziera, Ettore Bidoli, Erika Cecchin, Enrico Mini, Stefania Nobili, Sara Lonardi, Angela Buonadonna, Domenico Errante, Nicoletta Pella, Mario D'Andrea, Francesco De Marchi, Antonino De Paoli, Chiara Zanusso, Elena De Mattia, Renato Tassi, and Giuseppe Toffoli, “HLA-G 3 ' UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment,” Plos One, vol. 10, no. 12, 2015. View at Publisher · View at Google Scholar
  • Andréia Souza Gonçalves, Jéssica Petini Oliveira, Carolina Ferrari Piloni Oliveira, Tarcília Aparecida Silva, Elismauro Francisco Mendonça, Isabela Jubé Wastowski, and Aline Carvalho Batista, “Relevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesis,” Human Immunology, 2015. View at Publisher · View at Google Scholar
  • Fouad Aoun, Hampig R Kourie, Spyridon Sideris, Thierry Roumeguère, Roland van Velthoven, and Thierry Gil, “Checkpoint inhibitors in bladder and renal cancers: results and perspectives,” Immunotherapy, 2015. View at Publisher · View at Google Scholar
  • Xu, Lu, Cheng, Jiang, Xu, Long, Liu, Ni, Yu, and Liu, “High expression of human leukocyte antigen-G is associated with a poor prognosis in patients with PDAC,” Current Molecular Medicine, vol. 15, no. 4, pp. 360–367, 2015. View at Publisher · View at Google Scholar
  • Edgardo D. Carosella, Nathalie Rouas-Freiss, Diana Tronik-Le Roux, Philippe Moreau, and Joel LeMaout, “HLA-G: An Immune Checkpoint Molecule,” 2015. View at Publisher · View at Google Scholar
  • Nicolas Foray, Michel Bourguignon, and Nobuyuki Hamada, “Individual response to ionizing radiation,” Mutation Research/Reviews in Mutation Research, 2016. View at Publisher · View at Google Scholar
  • Marloes Swets, Lina Seneby, Arnoud Boot, Tom van Wezel, Hans Gelderblom, Cornelis J.H. van de Velde, Peter J. van den Elsen, and Peter J.K. Kuppen, “Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer,” Human Immunology, 2016. View at Publisher · View at Google Scholar
  • Simon Jasinski-Bergner, Verena Spath, Ofer Mandelboim, Arndt Hartmann, Barbara Seliger, Adi Reches, Christine Stoehr, Chiara Massa, Evamaria Gonschorek, Ena Wang, Francesco M. Marincola, Stefan Huettelmaier, Juliane Braun, Sven Wach, and Bernd Wullich, “Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma,” Oncotarget, vol. 7, no. 18, pp. 26866–26878, 2016. View at Publisher · View at Google Scholar
  • Anh Thu Nguyen-Lefebvre, Ashwin Ajith, Vera Portik-Dobos, Daniel D. Horuzsko, Laura L. Mulloy, and Anatolij Horuzsko, “Mouse models for studies of HLA-G functions in basic science and pre-clinical research,” Human Immunology, 2016. View at Publisher · View at Google Scholar
  • Marloes Swets, Marion H. König, Anniek Zaalberg, Neeltje G. Dekker-Ensink, Hans Gelderblom, Cornelis J.H. van de Velde, Peter J. van den Elsen, and Peter J.K. Kuppen, “HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases,” Human Immunology, 2016. View at Publisher · View at Google Scholar
  • Barbara Chifenti, Maria T. Locci, Giuseppe Trojano, Pietro Bottone, Maria G. Salerno, Paola Lenzi, Maria E. Filice, and Lorella Battini, “HLA-G intracellular expression in decidua trophoblasts in a normal term placenta: A confocal and transmission electron microscopy study,” Italian Journal of Gynaecology and Obstetrics, vol. 28, no. 1, pp. 27–34, 2016. View at Publisher · View at Google Scholar
  • C. E. M. Voorter, K. E. H. Gerritsen, M. Groeneweg, L. Wieten, and M. G. J. Tilanus, “The role of gene polymorphism in HLA class I splicing,” International Journal of Immunogenetics, 2016. View at Publisher · View at Google Scholar
  • Ching-Lien Wu, Signe Goul Svendsen, Adrien Riviere, François Desgrandchamps, Edgardo D. Carosella, and Joël LeMaoult, “Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4,” Human Immunology, 2016. View at Publisher · View at Google Scholar
  • Tania C. d’Almeida, Ibrahim Sadissou, Gilles Cottrell, Rachida Tahar, Philippe Moreau, Benoit Favier, Kabirou Moutairou, Eduardo A. Donadi, Achille Massougbodji, Nathalie Rouass-Freiss, David Courtin, and André Garcia, “Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis,” Malaria Journal, vol. 15, no. 1, 2016. View at Publisher · View at Google Scholar
  • Diego Antonio Costa Arantes, Andréia Souza Gonçalves, Bruno Correia Jham, Eliza Carla Barroso Duarte, Élbio Candido de Paula, Henrique Moura de Paula, Elismauro Francisco Mendonça, and Aline Carvalho Batista, “Evaluation of HLA-G, HLA-E and PD-L1 proteins in oral osteosarcomas,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2016. View at Publisher · View at Google Scholar
  • Natascha Köstlin, Anna-Lena Ostermeir, Bärbel Spring, Julian Schwarz, Alexander Marmé, Christina B. Walter, Christian F. Poets, and Christian Gille, “HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4,” European Journal of Immunology, 2016. View at Publisher · View at Google Scholar
  • Rahul C. Khanolkar, Alistair Lawrie, Ali Roghanian, Mark A. Vickers, Michail Kalogeropoulos, and Neil T. Young, “Leukocyte Ig-like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1,” Journal of Leukocyte Biology, vol. 100, no. 4, pp. 737–746, 2016. View at Publisher · View at Google Scholar
  • Inès Zidi, Olfa Dziri, Nour Zidi, Refaat Sebai, Nadia Boujelebene, Amna Ben Hassine, Hamza Ben Yahia, Ahmed Baligh Laaribi, Wafa Babay, Hela Rifi, Amel Mezlini, and Hanene Chelbi, “Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population,” Immunologic Research, 2016. View at Publisher · View at Google Scholar
  • Ines Zidi, Najla Kharrat, Rania abdelhedi, Amna Ben Hassine, Ahmed Baligh Laaribi, Hamza Ben Yahia, Nouha Abdelmouleh, Leila Abid, Ahmed Rebai, and Roberta Rizzo, “Non classical human leukocyte antigen (HLA-G, HLA-E, and HLA-F) in coronary artery disease,” Human Immunology, 2016. View at Publisher · View at Google Scholar
  • Mohammad Hashemi, Mahnaz Sandoughi, Seyed Amirhossein Fazeli, Gholamreza Bahari, Maryam Rezaei, and Zahra Zakeri, “Evaluation of HLA-G 14 bp Ins/Del and +3142G>C Polymorphism with Susceptibility and Early Disease Activity in Rheumatoid Arthritis,” Advances in Medicine, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Line Lisbeth Olesen, and Thomas Vauvert F. Hviid, “Upregulation of Soluble HLA-G in Chronic Left Ventricular Systolic Dysfunction,” Journal of Immunology Research, vol. 2016, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • G. Caocci, M. Greco, D. Fanni, G. Senes, R. Littera, S. Lai, P. Risso, C. Carcassi, G. Faa, and G. La Nasa, “HLA-G expression and role in advanced-stage classical Hodgkin lymphoma,” European Journal Of Histochemistry, vol. 60, no. 2, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • Paulina Własiuk, MacIej Putowski, and Krzysztof Giannopoulos, “PD1/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 70, pp. 1044–1058, 2016. View at Publisher · View at Google Scholar
  • Renata dos Santos Almeida, Alessandra Maria de Luna Ramos, Carlos Feitosa Luna, Francisco Pedrosa, Eduardo Antônio Donadi, and Norma Lucena-Silva, “Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia,” Cytokine, 2017. View at Publisher · View at Google Scholar
  • Barbara Seliger, “Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors,” Cytokine & Growth Factor Reviews, 2017. View at Publisher · View at Google Scholar
  • Mónica Villa-Álvarez, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, Alejandro López-Soto, Angel R. Payer, Esther Gonzalez-Garcia, Leticia Huergo-Zapico, and Segundo Gonzalez, “Ig-like transcript 2 (ILT2) suppresses T cell function in Chronic Lymphocytic Leukemia,” OncoImmunology, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Mojgan Mokhtari, Mohsen Taheri, Mohammad Hashemi, Safura Khazaeian, Gholamreza Bahari, Maryam Rezaei, and Alireza Nakhaee, “Evaluation of HLA-G 14-bp ins/del and +3142G>C polymorphisms with susceptibility to recurrent spontaneous abortion,” Taiwanese Journal of Obstetrics and Gynecology, vol. 56, no. 3, pp. 276–280, 2017. View at Publisher · View at Google Scholar
  • Nahla Abdel Moneim Hamed, Dalia Nafea, Mohamed Abd El Rahman, Ahmed Kasber, and Nabil El Halawani, “Soluble HLA-G: A novel marker in acute myeloid leukemia patients,” Acta Medica International, vol. 4, no. 1, pp. 51–55, 2017. View at Publisher · View at Google Scholar
  • Mohammad Hassan Heidari, Abolfazl Movafagh, Mohammad-Amin Abdollahifar, Shabnam Abdi, Mohamadreza Mashhoudi Barez, Hadi Azimi, Afshin Moradi, Amin Bagheri, Matineh Heidari, Jafar Hessam Mohseni, Maryam Tadayon, Hoda Mirsafian, and Mahdi Ghatrehsamani, “Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker,” Anatomy & Cell Biology, vol. 50, no. 1, pp. 69, 2017. View at Publisher · View at Google Scholar
  • José M. García-Heredia, and Amancio Carnero, “The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment,” Oncotarget, vol. 8, no. 58, pp. 98580–98597, 2017. View at Publisher · View at Google Scholar
  • Paola Muggeo, Maurizio Bianchi, Alessandra Sala, Piero Farruggia, Luciana Vinti, Edgardo D. Carosella, Barbara Famengo, Mariangela De Zorzi, Valli Re, Nicola Santoro, Salvatore Buffardi, Roberta Burnelli, Maurizio Mascarin, Laura Caggiari, Lara Mussolin, Emanuele Stefano d'Amore, Lia Martina, Caterina Elia, and Marta Pillon, “HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma,” Oncotarget, vol. 8, no. 62, pp. 105957–105970, 2017. View at Publisher · View at Google Scholar
  • Aifen Lin, and Wei-Hua Yan, “Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Hamza Ben Yahia, Wafa Babay, Daria Bortolotti, Nadia Boujelbene, Ahmed Baligh Laaribi, Nour Zidi, Mehdi Kehila, Hanène Chelbi, Abdellatif Boudabous, Karima Mrad, Amel Mezlini, Dario Di Luca, Hadda-Imene Ouzari, Roberta Rizzo, and Inès Zidi, “Increased plasmatic soluble HLA-G levels in endometrial cancer,” Molecular Immunology, vol. 99, pp. 82–86, 2018. View at Publisher · View at Google Scholar
  • Giuseppe Murdaca, Paola Calamaro, Francesca Lantieri, Simona Pigozzi, Luca Mastracci, Federica Grillo, Ottavia Magnani, Paola Ceppa, Francesco Puppo, and Roberto Fiocca, “HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact,” Virchows Archiv, 2018. View at Publisher · View at Google Scholar
  • Patrick Sorn, John C. Castle, Ugur Sahin, Sebastian Boegel, Thomas Bukur, and Martin Löwer, “HLA and proteasome expression body map,” BMC Medical Genomics, vol. 11, no. 1, 2018. View at Publisher · View at Google Scholar
  • Kevin Doello, “The role of trophoblastic epigenetic reprogrammation in benign tumor cells on malignant progression: a mollecular hypothesis,” Medical Hypotheses, 2018. View at Publisher · View at Google Scholar
  • Wise Young, “Future of Muse Cells,” Muse Cells, vol. 1103, pp. 309–315, 2018. View at Publisher · View at Google Scholar
  • Huirong Xu, Zuowei Sha, Aiqin Gao, Yuping Sun, Juan Li, Xinwen Li, Xiaojuan Wei, and Liyou Xu, “Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance,” Journal of Cancer Research and Therapeutics, vol. 14, no. 7, pp. 1655–1659, 2018. View at Publisher · View at Google Scholar
  • Rui Wan, Zi-Wei Wang, Guang-Yi Liu, An-Qi Cheng, Hui Li, Xu-Dong Peng, and Jun-Ming Ou, “Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer,” Cellular Physiology and Biochemistry, vol. 44, no. 5, pp. 1828–1841, 2018. View at Publisher · View at Google Scholar
  • Diego De Goycoechea, Gregoire Stalder, Filipe Martins, and Michel A. Duchosal, “Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives,” Journal of Oncology, vol. 2019, pp. 1–16, 2019. View at Publisher · View at Google Scholar
  • Nadia Boujelbene, Hamza Ben Yahia, Wafa Babay, Selma Gadria, Ines Zemni, Houda Azaiez, Sabrine Dhouioui, Nour Zidi, Rim Mchiri, Karima Mrad, Hadda‐Imene Ouzari, Lamia Charfi, and Inès Zidi, “HLA‐G, HLA‐E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma,” Hla, 2019. View at Publisher · View at Google Scholar
  • You Jiang, Jun Lu, Yue-E Wu, Xin Zhao, and Liang Li, “ Genetic variation in the HLA-G 3′UTR 14–bp insertion/deletion and the associated cancer risk: evidence from 25 case–control studies ,” Bioscience Reports, vol. 39, no. 5, pp. BSR20181991, 2019. View at Publisher · View at Google Scholar